Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States

Abstract

There is an epidemic of diabetes in Asia. Type 2 diabetes develops in East Asian patients at a lower mean body mass index (BMI) compared with those of European descent. At any given BMI, East Asians have a greater amount of body fat and a tendency to visceral adiposity. In Asian patients, diabetes develops at a younger age and is characterized by early β cell dysfunction in the setting of insulin resistance, with many requiring early insulin treatment. The increasing proportion of young‐onset and childhood type 2 diabetes is posing a particular threat, with these patients being at increased risk of developing diabetic complications. East Asian patients with type 2 diabetes have a higher risk of developing renal complications than Europeans and, with regard to cardiovascular complications, a predisposition for developing strokes. In addition to cardiovascular–renal disease, cancer is emerging as the other main cause of mortality. While more research is needed to explain these interethnic differences, urgent and concerted actions are needed to raise awareness, facilitate early diagnosis, and encourage preventive strategies to combat these growing disease burdens.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 231

1. 1.

   Diabetes Atlas. 2011.

   Not in our library

2. 2.

   Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368:1681-1688.

   Not in our library10.1016/s0140-6736(06)69703-1

3. 3.

   Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129-2140.

   Not in our library10.1001/jama.2009.726

4. 4.

   Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet. 2010;375:408-418.

   Not in our library10.1016/s0140-6736(09)60937-5

5. 5.

   Ma RC, Tong PC, Holt R, Goldstein B, Flyvbjerg A, Cockram CS. “Epidemiology of type 2 diabetes”. Textbook of Diabetes. 2010;45-68.

   Not in our library

6. 6.

   Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N. Engl. J. Med. 2010;362:1090-1101.

   Not in our library10.1056/nejmoa0908292

7. 7.

   Li H, Oldenburg B, Chamberlain C, et al. Diabetes prevalence and determinants in adults in China mainland from 2000 to 2010: a systematic review. Diabetes Res. Clin. Pract. 2012;98:226-235.

   Not in our library10.1016/j.diabres.2012.05.010

8. 8.

   Wong KC, Wang Z. Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res. Clin. Pract. 2006;73:126-134.

   Not in our library10.1016/j.diabres.2006.01.007

9. 9.

   National Diabetes Fact Sheet: National Estimates and General Information on Diabetes in the United States, 2011. 2011.

   Not in our library

10. 10.

    Dowse GK, Zimmet PZ, King H. Relationship between prevalence of impaired glucose tolerance and NIDDM in a population. Diabetes Care. 1991;14:968-974.

    Not in our library10.2337/diacare.14.11.968

11. 11.

    Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat. Rev. Endocrinol. 2012;8:228-236.

    Not in our library10.1038/nrendo.2011.183

12. 12.

    Age and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care. 2003;26:1770-1780.

    Not in our library10.2337/diacare.26.6.1770

13. 13.

    Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care. 2003;26:61-69.

    Not in our library10.2337/diacare.26.1.61

14. 14.

    Jiang YD, Chang CH, Tai TY, et al. Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000–2009 Nationwide Health Insurance database. J. Formos. Med. Assoc. 2012;111:599-604.

    Not in our library10.1016/j.jfma.2012.09.014

15. 15.

    Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35(Suppl. 1):S64-S71.

    Not in our library10.2337/dc12-s064

16. 16.

    Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia. 2006.

    Not in our library

17. 17.

    Ko GTC, Chan JCN, Woo J, Cockram CS. The use of the 1997 American Diabetes Association Diagnostic criteria in a Hong Kong Chinese population. Diabetes Care. 1998;21:2094-2097.

    Not in our library10.2337/diacare.21.12.2094

18. 18.

    Qiao Q, Nakagami T, Tuomilehto J, et al. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia. 2000;43:1470-1475.

    Not in our library10.1007/s001250051557

19. 19.

    Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. 2011;25.

    Not in our library

20. 20.

    Dagogo-Jack S. Pitfalls in the use of HbA(1)(c) as a diagnostic test: the ethnic conundrum. Nat. Rev. Endocrinol. 2010;6:589-593.

    Not in our library10.1038/nrendo.2010.126

21. 21.

    Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet. Med. 2007;24:333-343.

    Not in our library10.1111/j.1464-5491.2007.02106.x

22. 22.

    Anand SS, Razak F, Vuksan V, et al. Diagnostic strategies to detect glucose intolerance in a multiethnic population. Diabetes Care. 2003;26:290-296.

    Not in our library10.2337/diacare.26.2.290

23. 23.

    Herman WH, Ma Y, Uwaifo G, et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007;30:2453-2457.

    Not in our library10.2337/dc06-2003

24. 24.

    Bao Y, Ma X, Li H, et al. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. Br. Med. J. 2010;340:c2249.

    Not in our library10.1136/bmj.c2249

25. 25.

    Ko GTC, Chan JCN, Yeung VTF, et al. The combined use of a fasting plasma glucose concentration and glycated hemoglobin or fructosamine predicts the likelihood of having diabetes mellitus in high risk subjects. Diabetes Care. 1998;21:1221-1225.

    Not in our library10.2337/diacare.21.8.1221

26. 26.

    Jia WP, Pang C, Chen L, et al. Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia. 2007;50:286-292.

    Not in our library10.1007/s00125-006-0503-1

27. 27.

    Ko GTC, Chan JCN, Woo J, Cockram CS. Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple arthropometric indexes in Hong Kong Chinese. Int. J. Obes. 1999;23:1136-1142.

    Not in our library10.1038/sj.ijo.0801043

28. 28.

    McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991;337:382-386.

    Not in our library10.1016/0140-6736(91)91164-p

29. 29.

    Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int. J. Obes. Relat. Metab. Disord. 1998;22:1164-1171.

    Not in our library10.1038/sj.ijo.0800741

30. 30.

    He M, Tan KC, Li ET, Kung AW. Body fat determination by dual energy X-ray absorptiometry and its relation to body mass index and waist circumference in Hong Kong Chinese. Int. J. Obes. Related Metab. Dis. 2001;25:748-752.

    Not in our library10.1038/sj.ijo.0801612

31. 31.

    The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. 2000.

    Not in our library

32. 32.

    Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.

    Not in our library10.1016/s0140-6736(03)15268-3

33. 33.
    Body Mass Index and Diabetes in Asia: A Cross-Sectional Pooled Analysis of 900,000 Individuals in the Asia Cohort Consortium · 2011

    No notice
34. 34.

    Koh-Banerjee P, Wang Y, Hu FB, et al. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am. J. Epidemiol. 2004;159:1150-1159.

    Not in our library10.1093/aje/kwh167

35. 35.

    Wang Y, Rimm EB, Stampfer MJ, et al. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am. J. Clin. Nutr. 2005;81:555-563.

    Not in our library10.1093/ajcn/81.3.555

36. 36.

    Huxley R, James WP, Barzi F, et al. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes. Rev. 2008;9(Suppl. 1):53-61.

    Not in our library10.1111/j.1467-789x.2007.00439.x

37. 37.

    Nyamdorj R, Pitkaniemi J, Tuomilehto J, et al. Ethnic comparison of the association of undiagnosed diabetes with obesity. Int. J. Obes. 2010;34:332-339.

    Not in our library10.1038/ijo.2009.225

38. 38.

    Stevens J, Truesdale KP, Katz EG, Cai J. Impact of body mass index on incident hypertension and diabetes in Chinese Asians, American Whites, and American Blacks: the People's Republic of China Study and the Atherosclerosis Risk in Communities Study. Am. J. Epidemiol. 2008;167:1365-1374.

    Not in our library10.1093/aje/kwn060

39. 39.

    Chiu M, Austin PC, Manuel DG, et al. Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care. 2011;34:1741-1748.

    Not in our library10.2337/dc10-2300

40. 40.

    Ma Y, Hebert JR, Manson JE, et al. Determinants of racial/ethnic disparities in incidence of diabetes in postmenopausal women in the U.S.: the Women's Health Initiative 1993–2009. Diabetes Care. 2012;35:2226-2234.

    Not in our library10.2337/dc12-0412

Cited by papers we hold 11

• Gray and white matter abnormality in patients with T2DM-related cognitive dysfunction: a systemic review and meta-analysis · 2022
  Not checked
• A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives · 2021
  No notice
• Metabolomic signatures for visceral adiposity and dysglycaemia in Asian Chinese and Caucasian European adults: the cross-sectional TOFI_Asia study · 2020
  Not checked
• Plasma Fetuin-A Levels and Risk of Type 2 Diabetes Mellitus in A Chinese Population: A Nested Case-Control Study · 2019
  Not checked
• Determinants of cognitive performance and decline in 20 diverse ethno-regional groups: A COSMIC collaboration cohort study · 2019
  No notice
• Statin Use and Cancer Incidence in Patients with Type 2 Diabetes Mellitus: A Network Meta-Analysis · 2018
  Not checked
• Nanoparticle-Encapsulated Curcumin Inhibits Diabetic Neuropathic Pain Involving the P2Y12 Receptor in the Dorsal Root Ganglia · 2018
  Not checked
• Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes · 2017
  No notice
• Branched-chain and aromatic amino acid profiles and diabetes risk in Chinese populations · 2016
  No notice
• Plasma Free Amino Acid Profiles Predict Four-Year Risk of Developing Diabetes, Metabolic Syndrome, Dyslipidemia and Hypertension in Japanese Population · 2015
  No notice
• Nongenetic Determinants of Age at Menarche: A Systematic Review · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.